·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á ±â»çÀÔ·Â : 02.10.04 11:05:40 0 °¡ ÇÃÄ£Ãß°¡ ȸ¿ø °£ ÈÇÕÀÇ Àå ¸¶·Ã...ȸ¿ø 50¿©¸í Âü¿© µµºÀ¤ý°ºÏ±¸¾à»çȸ(ȸÀå ½Å»óÁ÷)´Â 3ÀÏ Á¦2ȸ °¡Á·µî¹Ý´ëȸ¸¦ °³ÃÖÇß´Ù. µµºÀ±¸¾à ȸ¿ø 50¿©¸íÀº µµºÀ»ê ¿ìÀÌ¾Ï µî¹ÝÀ» ÅëÇØ ȸ¿ø°£ÀÇ Ä§¸ñµµ¸ð¿Í ÈÇÕÀÇ ÀÚ¸®¸¦ ¸¶·ÃÇß´Ù. ½Å»óÁ÷ ȸÀåÀº "À̹ø Çà»ç¸¦ ÅëÇØ ȸ¿ø µé °£ ¼·Î Çù·ÂÇØ Çϳª µÇ´Â µµºÀ±¸¾àÀ» ¸¸µéÀÚ"¸ç ȸ¿ø ¹× µ¿¹Ý °¡Á·µéÀ» °Ý·ÁÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Çѹ̱׷ì 7¿ù ¼ö½Ãä¿ë [°¢ ºÎ¹®º°] ¹Ù·Î°¡±â ¸¶ÄÉÆÃºÎ ETC PM ¸ðÁý ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â HK À̳뿣 ´ë¼Ò°øÀå °ü¸®¾à»ç ¸ðÁý(ÃæºÏ À½¼º) ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Á¦Á¶/ǰÁú°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â 2025³â Á¦2Â÷ ±¹¹Î°Ç°º¸Çè°ø´Ü Àü¹®ÀηÂ(¾à»ç) ä¿ë ¹Ù·Î°¡±â ¹ÙÀ̳ؽº[ºÎ»ê] °ü¸®¾à»ç(µµ¸Å¾÷) / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â õ¿¬¹°ÀǾ࿬±¸ÆÀ(Á¦Á¦¿¬±¸) °æ·ÂÁ÷¿ø ¸ðÁý ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Sr. Market Access Specialist / Product Manager (Oncology) ä¿ë ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¦¾à¸¶ÄÉÆÃÆÀ ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á ±â»çÀÔ·Â : 02.10.04 11:05:40 0 °¡ ÇÃÄ£Ãß°¡ ȸ¿ø °£ ÈÇÕÀÇ Àå ¸¶·Ã...ȸ¿ø 50¿©¸í Âü¿© µµºÀ¤ý°ºÏ±¸¾à»çȸ(ȸÀå ½Å»óÁ÷)´Â 3ÀÏ Á¦2ȸ °¡Á·µî¹Ý´ëȸ¸¦ °³ÃÖÇß´Ù. µµºÀ±¸¾à ȸ¿ø 50¿©¸íÀº µµºÀ»ê ¿ìÀÌ¾Ï µî¹ÝÀ» ÅëÇØ ȸ¿ø°£ÀÇ Ä§¸ñµµ¸ð¿Í ÈÇÕÀÇ ÀÚ¸®¸¦ ¸¶·ÃÇß´Ù. ½Å»óÁ÷ ȸÀåÀº "À̹ø Çà»ç¸¦ ÅëÇØ ȸ¿ø µé °£ ¼·Î Çù·ÂÇØ Çϳª µÇ´Â µµºÀ±¸¾àÀ» ¸¸µéÀÚ"¸ç ȸ¿ø ¹× µ¿¹Ý °¡Á·µéÀ» °Ý·ÁÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Çѹ̱׷ì 7¿ù ¼ö½Ãä¿ë [°¢ ºÎ¹®º°] ¹Ù·Î°¡±â ¸¶ÄÉÆÃºÎ ETC PM ¸ðÁý ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â HK À̳뿣 ´ë¼Ò°øÀå °ü¸®¾à»ç ¸ðÁý(ÃæºÏ À½¼º) ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Á¦Á¶/ǰÁú°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â 2025³â Á¦2Â÷ ±¹¹Î°Ç°º¸Çè°ø´Ü Àü¹®ÀηÂ(¾à»ç) ä¿ë ¹Ù·Î°¡±â ¹ÙÀ̳ؽº[ºÎ»ê] °ü¸®¾à»ç(µµ¸Å¾÷) / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â õ¿¬¹°ÀǾ࿬±¸ÆÀ(Á¦Á¦¿¬±¸) °æ·ÂÁ÷¿ø ¸ðÁý ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Sr. Market Access Specialist / Product Manager (Oncology) ä¿ë ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¦¾à¸¶ÄÉÆÃÆÀ ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á ±â»çÀÔ·Â : 02.10.04 11:05:40 0 °¡ ÇÃÄ£Ãß°¡ ȸ¿ø °£ ÈÇÕÀÇ Àå ¸¶·Ã...ȸ¿ø 50¿©¸í Âü¿© µµºÀ¤ý°ºÏ±¸¾à»çȸ(ȸÀå ½Å»óÁ÷)´Â 3ÀÏ Á¦2ȸ °¡Á·µî¹Ý´ëȸ¸¦ °³ÃÖÇß´Ù. µµºÀ±¸¾à ȸ¿ø 50¿©¸íÀº µµºÀ»ê ¿ìÀÌ¾Ï µî¹ÝÀ» ÅëÇØ ȸ¿ø°£ÀÇ Ä§¸ñµµ¸ð¿Í ÈÇÕÀÇ ÀÚ¸®¸¦ ¸¶·ÃÇß´Ù. ½Å»óÁ÷ ȸÀåÀº "À̹ø Çà»ç¸¦ ÅëÇØ ȸ¿ø µé °£ ¼·Î Çù·ÂÇØ Çϳª µÇ´Â µµºÀ±¸¾àÀ» ¸¸µéÀÚ"¸ç ȸ¿ø ¹× µ¿¹Ý °¡Á·µéÀ» °Ý·ÁÇß´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : µµºÀ±¸¾à, µµºÀ»ê °¡Á·µî»ê´ëȸ ¼º·á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö